FindMyRecallSubscribe
Class II: temporary or reversible health riskOngoing

Lupin Pharmaceuticals Glucagon Emergency Kit for Low Blood Sugar Recall

Glucagon Emergency Kit for Low Blood Sugar, Glucagon for Injection USP, 1mg per vial, D…

Lupin Pharmaceuticals Inc. · Naples, FL

Risk level
Class II
Reported by FDA
Jul 8, 2026
Recall ID
D-0723-2026
Check your lot numberHow we source this data

Summary

Lupin Pharmaceuticals recalled Glucagon Emergency Kit for Low Blood Sugar starting Jun 23, 2026. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0723-2026 on Jul 8, 2026. Reason: CGMP deviation: OOS result observed for the Gliding Force functionality test during 12-month long term stability testing. Status: Ongoing.

Why it was recalled

CGMP deviation: OOS result observed for the Gliding Force functionality test during 12-month long term stability testing.

Product description

Glucagon Emergency Kit for Low Blood Sugar, Glucagon for Injection USP, 1mg per vial, Diluent for Glucagon, 1 mL syringe, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Naples, FL 34108, Manufactured by: Lupin Limited, Nagpur - 441108, INDIA, NDC 70748-311-01

Lot numbers, UPCs & expiration codes

Kit Lots: WB00010, Exp. Date Jan 2027; WB00017, WB00019, Exp. Date Feb 2027; WB00070, Exp. Date Jun 2027; WB00077, WB00078, Exp. Date Jul 2027; WB00130, Exp. Date Nov 2027.

Where it was sold

Nationwide within the U.S.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0723-2026
Classification
Class II
Status
Ongoing
Recall initiated
Jun 23, 2026
FDA report date
Jul 8, 2026
Quantity
64,894 units
Recall type
Voluntary: Firm initiated
Recalling firm
Lupin Pharmaceuticals Inc.

Original FDA data

Every field from FDA enforcement report D-0723-2026, exactly as published.

Show all FDA fields
City
Naples
State
FL
Status
Ongoing
Country
United States
Event ID
99296
Address
5801 Pelican Bay Blvd Ste 500
Code information
Kit Lots: WB00010, Exp. Date Jan 2027; WB00017, WB00019, Exp. Date Feb 2027; WB00070, Exp. Date Jun 2027; WB00077, WB00078, Exp. Date Jul 2027; WB00130, Exp. Date Nov 2027.
Postal code
34108-2734
Report date
Jul 8, 2026
Product type
Drugs
Recall number
D-0723-2026
Classification
Class II
Recalling firm
Lupin Pharmaceuticals Inc.
Product quantity
64,894 units
Reason for recall
CGMP deviation: OOS result observed for the Gliding Force functionality test during 12-month long term stability testing.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Glucagon Emergency Kit for Low Blood Sugar, Glucagon for Injection USP, 1mg per vial, Diluent for Glucagon, 1 mL syringe, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Naples, FL 34108, Manufactured by: Lupin Limited, Nagpur - 441108, INDIA, NDC 70748-311-01
Distribution pattern
Nationwide within the U.S.
Recall initiation date
Jun 23, 2026
Initial firm notification
E-Mail
Center classification date
Jul 23, 2026

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0723-2026, published Jul 8, 2026. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls